Image Source: Pixabay
The GMO mosquito has it big this year as the FDA has approved the mosquito developed by Oxitec in order to combat Zika. OX513A, a genetically modified male Aedes aegypti mosquito has been given the federal green signal for use in field trials in a small Florida neighbourhood.
This approval by FDA comes after considering thousands of public comments and after a rigorous Environmental impact (EA) and a preliminary “Finding of No Significant Impact (FONSI)” trial that concluded that the proposed field trial will not have significant impacts on the environment.
“We’re really pleased to announce the FDA finished their review and has found no significant impact of the release of our mosquito on human health or the environment,” Oxitec CEO Hadyn Parry said. “This is especially timely, given the recent finding of Zika transmission by local mosquitoes in a Miami neighborhood.”
The female Aedes aegypti mosquitoes…
View original post 369 more words